Aseel Sukik, Sara Mohamed, Mhd-Baraa Habib, Sundus Sardar, Bashar Tanous, Raad Tahtouh, Mouhand F H Mohamed
{"title":"与桥本氏甲状腺功能减退症相关的罕见晚发型巴塞杜氏病:病例报告与文献综述","authors":"Aseel Sukik, Sara Mohamed, Mhd-Baraa Habib, Sundus Sardar, Bashar Tanous, Raad Tahtouh, Mouhand F H Mohamed","doi":"10.1155/2020/5647273","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background</i>. The shift of Graves' disease (GD) to Hashimoto's disease- (HD-) related hypothyroidism is well established. However, the opposite is rare. This is likely to the loss of critical thyroid mass available for stimulation by thyroid hormone receptor stimulating antibody, making this shift unusual. Herein, we report a young lady with a late shift from HD into GD and present a scoping literature review. <i>Case presentation</i>. We report a twenty-five-year-old lady with a sixteen-year-history of Hashimoto's-related hypothyroidism stable on levothyroxine. While following in the clinic, she started developing thyrotoxic symptoms in the form of anxiety, weight loss, and palpitation. Physical examination was remarkable for mild exophthalmos. The thyroid function test confirmed hyperthyroidism. Levothyroxine-induced hyperthyroidism was initially suspected; however, the symptoms did not improve despite reducing and stopping levothyroxine. Subsequent workup confirmed the diagnosis of GD. <i>Discussion and Conclusion</i>. This case highlights a unique association that has significant diagnostic and management implications. This shift should be considered when hyperthyroidism persists despite reducing or stopping levothyroxine. The diagnosis is made utilizing antibody titers and radioiodine update scan. While the management depends on the disease's stage and the treating physician preference, antithyroid agents can be used initially. Following up these patients is essential as the shift can be transient.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2020 ","pages":"5647273"},"PeriodicalIF":0.9000,"publicationDate":"2020-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787859/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Unusual Late-Onset Graves' Disease following Hashimoto's Related Hypothyroidism: A Case Report and Literature Review.\",\"authors\":\"Aseel Sukik, Sara Mohamed, Mhd-Baraa Habib, Sundus Sardar, Bashar Tanous, Raad Tahtouh, Mouhand F H Mohamed\",\"doi\":\"10.1155/2020/5647273\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Background</i>. The shift of Graves' disease (GD) to Hashimoto's disease- (HD-) related hypothyroidism is well established. However, the opposite is rare. This is likely to the loss of critical thyroid mass available for stimulation by thyroid hormone receptor stimulating antibody, making this shift unusual. Herein, we report a young lady with a late shift from HD into GD and present a scoping literature review. <i>Case presentation</i>. We report a twenty-five-year-old lady with a sixteen-year-history of Hashimoto's-related hypothyroidism stable on levothyroxine. While following in the clinic, she started developing thyrotoxic symptoms in the form of anxiety, weight loss, and palpitation. Physical examination was remarkable for mild exophthalmos. The thyroid function test confirmed hyperthyroidism. Levothyroxine-induced hyperthyroidism was initially suspected; however, the symptoms did not improve despite reducing and stopping levothyroxine. Subsequent workup confirmed the diagnosis of GD. <i>Discussion and Conclusion</i>. This case highlights a unique association that has significant diagnostic and management implications. This shift should be considered when hyperthyroidism persists despite reducing or stopping levothyroxine. The diagnosis is made utilizing antibody titers and radioiodine update scan. While the management depends on the disease's stage and the treating physician preference, antithyroid agents can be used initially. Following up these patients is essential as the shift can be transient.</p>\",\"PeriodicalId\":9621,\"journal\":{\"name\":\"Case Reports in Endocrinology\",\"volume\":\"2020 \",\"pages\":\"5647273\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2020-12-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787859/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/5647273\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/5647273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景。巴塞杜氏病(GD)向桥本氏病(HD)相关甲状腺功能减退症的转变已得到公认。然而,相反的情况却很少见。这可能是由于甲状腺激素受体刺激抗体可刺激的临界甲状腺量减少,使得这种转变并不常见。在此,我们报告了一名从 HD 晚期转变为 GD 的年轻女性,并对相关文献进行了综述。病例介绍。我们报告了一位二十五岁的女士,她有十六年的桥本氏相关甲状腺功能减退病史,一直稳定服用左甲状腺素。就诊期间,她开始出现焦虑、体重减轻和心悸等甲亢症状。体格检查发现她有轻度眼球外翻。甲状腺功能检查证实她患有甲状腺功能亢进症。最初怀疑是左甲状腺素诱发的甲状腺功能亢进症;然而,尽管减少和停用了左甲状腺素,症状仍未改善。随后的检查证实了 GD 的诊断。讨论与结论。本病例强调了一种独特的关联,对诊断和管理具有重要意义。当减少或停用左甲状腺素后甲状腺功能仍然亢进时,应考虑这种转变。通过抗体滴度和放射性碘更新扫描可做出诊断。虽然治疗方法取决于疾病的阶段和主治医生的偏好,但最初可以使用抗甲状腺药物。由于这种转变可能是一过性的,因此对这些患者进行随访非常重要。
The Unusual Late-Onset Graves' Disease following Hashimoto's Related Hypothyroidism: A Case Report and Literature Review.
Background. The shift of Graves' disease (GD) to Hashimoto's disease- (HD-) related hypothyroidism is well established. However, the opposite is rare. This is likely to the loss of critical thyroid mass available for stimulation by thyroid hormone receptor stimulating antibody, making this shift unusual. Herein, we report a young lady with a late shift from HD into GD and present a scoping literature review. Case presentation. We report a twenty-five-year-old lady with a sixteen-year-history of Hashimoto's-related hypothyroidism stable on levothyroxine. While following in the clinic, she started developing thyrotoxic symptoms in the form of anxiety, weight loss, and palpitation. Physical examination was remarkable for mild exophthalmos. The thyroid function test confirmed hyperthyroidism. Levothyroxine-induced hyperthyroidism was initially suspected; however, the symptoms did not improve despite reducing and stopping levothyroxine. Subsequent workup confirmed the diagnosis of GD. Discussion and Conclusion. This case highlights a unique association that has significant diagnostic and management implications. This shift should be considered when hyperthyroidism persists despite reducing or stopping levothyroxine. The diagnosis is made utilizing antibody titers and radioiodine update scan. While the management depends on the disease's stage and the treating physician preference, antithyroid agents can be used initially. Following up these patients is essential as the shift can be transient.